1993European NeuropsychopharmacologyOpen access

Pharmacological treatment of social phobia: Traditional MAOIs and moclobemide

Michael R. Liebowitz

Open full text 1 citations

Abstract

Social phobia appears highly responsive to pharmacological therapy. Efficacy is best documented for the traditional monoamine oxidase inhibitor (MAOI) phenelzine. The reversible MAOI moclobemide also appears to show promise or treating social phobia.

About this research paper

What this paper is about

Social phobia appears highly responsive to pharmacological therapy. Efficacy is best documented for the traditional monoamine oxidase inhibitor (MAOI) phenelzine. The reversible MAOI moclobemide also appears to show promise or treating social phobia.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Social phobia appears highly responsive to pharmacological therapy. Efficacy is best documented for the traditional monoamine oxidase inhibitor (MAOI) phenelzine. The reversible MAOI moclobemide also appears to show promise or treating social phobia.

Key concepts: Moclobemide, Phenelzine, Monoamine oxidase inhibitor, Monoamine oxidase, Psychology, Phobias, Psychotherapist, Psychiatry

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacological treatment of social phobia: Traditional MAOIs and moclobemide — Research Paper | ScholarLens